Follow
Yin Mo
Yin Mo
Consultant in Infectious Disease, National University Hospital, Singapore
Verified email at nuhs.edu.sg
Title
Cited by
Cited by
Year
Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a …
PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ...
Jama 320 (10), 984-994, 2018
4152018
A review of treatment modalities for Middle East respiratory syndrome
Y Mo, D Fisher
Journal of Antimicrobial Chemotherapy 71 (12), 3340-3350, 2016
1162016
Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia …
PNA Harris, M Yin, R Jureen, J Chew, J Ali, S Paynter, DL Paterson, ...
Antimicrobial resistance and infection control 4 (1), 1-10, 2015
592015
Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and …
PNA Harris, NL Ben Zakour, LW Roberts, AM Wailan, HM Zowawi, ...
Journal of Antimicrobial Chemotherapy 73 (3), 634-642, 2018
502018
A meta‐analysis of the association between Helicobacter pylori (H. pylori) infection and hyperemesis gravidarum
QX Ng, N Venkatanarayanan, MLZQ De Deyn, CYX Ho, Y Mo, WS Yeo
Helicobacter 23 (1), e12455, 2018
472018
Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). 2018. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality …
PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ...
JAMA 320 (10), 984-994, 0
35
Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study
A Henderson, DL Paterson, MD Chatfield, PA Tambyah, DC Lye, PP De, ...
Clinical Infectious Diseases 73 (11), e3842-e3850, 2021
342021
Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults
PNA Harris, AD Wang, M Yin, CK Lee, S Archuleta
The Lancet Infectious Diseases 14 (11), 1043, 2014
332014
Using machine learning to guide targeted and locally-tailored empiric antibiotic prescribing in a children's hospital in Cambodia
M Oonsivilai, Y Mo, N Luangasanatip, Y Lubell, T Miliya, P Tan, L Loeuk, ...
Wellcome open research 3, 2018
302018
Zika virus—a review for clinicians
Y Mo, BM Alferez Salada, PA Tambyah
British Medical Bulletin 119 (1), 25-36, 2016
192016
Non-adherence in non-inferiority trials: pitfalls and recommendations
Y Mo, C Lim, JA Watson, NJ White, BS Cooper
bmj 370, 2020
182020
A systematic review of the use of rifaximin for Clostridium difficile infections
QX Ng, W Loke, NX Foo, Y Mo, WS Yeo, AYS Soh
Anaerobe 55, 35-39, 2019
152019
Relating knowledge, attitude and practice of antibiotic use to extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage: results of a cross-sectional community survey
Y Mo, I Seah, PSP Lye, XLJ Kee, KYM Wong, KKK Ko, RTH Ong, ...
BMJ open 9 (3), e023859, 2019
142019
Optimising trial designs to identify appropriate antibiotic treatment durations
KB Pouwels, M Yin, CC Butler, BS Cooper, S Wordsworth, AS Walker, ...
BMC medicine 17 (1), 1-7, 2019
132019
Transmission of community-and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study
Y Mo, DW Eyre, SF Lumley, TM Walker, RH Shaw, D O’Donnell, L Butcher, ...
PLoS medicine 18 (10), e1003816, 2021
112021
N. the Australasian Society for Infectious Disease Clinical Research. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or klebsiella …
PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee
Jama 320 (10), 984-994, 2018
112018
Considerations in the use of slit lamp shields to reduce the risk of respiratory virus transmission in coronavirus disease 2019
SC Ong, JX Yap, TYF Tay, Y Mo, SC Loon, V Koh
Current opinion in ophthalmology 31 (5), 374-379, 2020
92020
Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance
R Niehus, E van Kleef, Y Mo, A Turlej-Rogacka, C Lammens, Y Carmeli, ...
Elife 9, e49206, 2020
82020
Infection, antibiotics, and patient outcomes in the intensive care unit
M Yin, PA Tambyah, EN Perencevich
JAMA 323 (15), 1451-1452, 2020
82020
The socio-economic impact of multidrug-resistant nosocomial infections: a qualitative study
Y Mo, I Low, SK Tambyah, PA Tambyah
Journal of Hospital Infection 102 (4), 454-460, 2019
82019
The system can't perform the operation now. Try again later.
Articles 1–20